Asked by: Lee Anderson (Reform UK - Ashfield)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure health professionals are adequately trained on the differences between Functional Neurological Disorder and other neurological conditions.
Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)
The Department recognises the need to improve awareness and understanding of functional neurological disorder (FND) across the health system.
The Royal College of General Practitioners provides a learning course that includes a dedicated module on recognising and explaining FND, helping general practitioners (GPs) to improve early identification and understanding of the condition. Further support is provided through guidance published by the National Institute for Care Excellence (NICE) on suspected neurological conditions: recognition and referral, reference code NG127, which includes detailed recommendations on recognising symptoms commonly present in FND and appropriate referral pathways.
NICE also provides a Clinical Knowledge Summary (CKS) on FND, offering practical, evidence‑based advice on diagnosis and management, supporting clinicians in distinguishing FND from structural or degenerative neurological disease.
FND is also included in a NICE guideline on rehabilitation for chronic neurological disorders and acquired brain injury, reference code NG252, published in October 2025. This further strengthens the evidence base and ensure clinicians have clear, up‑to‑date guidance on assessment and management within a broader neurological context.
Together, these resources ensure that health professionals, across primary, secondary, and specialist services, have access to robust, evidence‑based tools to support accurate differentiation between FND and other neurological conditions.
GPs are required to undertake continuing professional development to maintain and update their clinical knowledge, and they can access a range of training resources through professional bodies, royal colleges, and National Health Service‑funded education platforms. Decisions about mandatory training requirements are made only where there is a clear and evidence‑based need, and the current approach remains to ensure that GPs have the flexibility to tailor their learning to the needs of their patient populations.
Asked by: Lee Anderson (Reform UK - Ashfield)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure General Practitioners are sufficiently trained on Functional Neurological Disorder.
Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)
The Department recognises the need to improve awareness and understanding of functional neurological disorder (FND) across the health system.
The Royal College of General Practitioners provides a learning course that includes a dedicated module on recognising and explaining FND, helping general practitioners (GPs) to improve early identification and understanding of the condition. Further support is provided through guidance published by the National Institute for Care Excellence (NICE) on suspected neurological conditions: recognition and referral, reference code NG127, which includes detailed recommendations on recognising symptoms commonly present in FND and appropriate referral pathways.
NICE also provides a Clinical Knowledge Summary (CKS) on FND, offering practical, evidence‑based advice on diagnosis and management, supporting clinicians in distinguishing FND from structural or degenerative neurological disease.
FND is also included in a NICE guideline on rehabilitation for chronic neurological disorders and acquired brain injury, reference code NG252, published in October 2025. This further strengthens the evidence base and ensure clinicians have clear, up‑to‑date guidance on assessment and management within a broader neurological context.
Together, these resources ensure that health professionals, across primary, secondary, and specialist services, have access to robust, evidence‑based tools to support accurate differentiation between FND and other neurological conditions.
GPs are required to undertake continuing professional development to maintain and update their clinical knowledge, and they can access a range of training resources through professional bodies, royal colleges, and National Health Service‑funded education platforms. Decisions about mandatory training requirements are made only where there is a clear and evidence‑based need, and the current approach remains to ensure that GPs have the flexibility to tailor their learning to the needs of their patient populations.
Asked by: Lee Anderson (Reform UK - Ashfield)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if he will make training on Functional Neurological Disorder mandatory for General Practitioners.
Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)
The Department recognises the need to improve awareness and understanding of functional neurological disorder (FND) across the health system.
The Royal College of General Practitioners provides a learning course that includes a dedicated module on recognising and explaining FND, helping general practitioners (GPs) to improve early identification and understanding of the condition. Further support is provided through guidance published by the National Institute for Care Excellence (NICE) on suspected neurological conditions: recognition and referral, reference code NG127, which includes detailed recommendations on recognising symptoms commonly present in FND and appropriate referral pathways.
NICE also provides a Clinical Knowledge Summary (CKS) on FND, offering practical, evidence‑based advice on diagnosis and management, supporting clinicians in distinguishing FND from structural or degenerative neurological disease.
FND is also included in a NICE guideline on rehabilitation for chronic neurological disorders and acquired brain injury, reference code NG252, published in October 2025. This further strengthens the evidence base and ensure clinicians have clear, up‑to‑date guidance on assessment and management within a broader neurological context.
Together, these resources ensure that health professionals, across primary, secondary, and specialist services, have access to robust, evidence‑based tools to support accurate differentiation between FND and other neurological conditions.
GPs are required to undertake continuing professional development to maintain and update their clinical knowledge, and they can access a range of training resources through professional bodies, royal colleges, and National Health Service‑funded education platforms. Decisions about mandatory training requirements are made only where there is a clear and evidence‑based need, and the current approach remains to ensure that GPs have the flexibility to tailor their learning to the needs of their patient populations.
Asked by: Adam Dance (Liberal Democrat - Yeovil)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what discussions he has had on the potential merits of producing a National Maternity Strategy.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
The Government is establishing a National Maternity and Neonatal Taskforce, chaired by my Rt Hon. Friend, the Secretary of State for Health and Social Care.
The taskforce will address the recommendations that are expected this Spring from the National Maternity and Neonatal Investigation through the development of a new national action plan that will drive improvements across maternity and neonatal care. The taskforce will also hold the system to account for the delivery of this plan, as well as improving outcomes and experiences for women and babies.
Asked by: Adam Dance (Liberal Democrat - Yeovil)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether he will appoint a Maternity Commissioner.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
There are no current plans to appoint a Maternity Commissioner. The Government has commissioned an independent National Investigation into maternity and neonatal care, chaired by Baroness Amos, which is expected to make recommendations this spring. My Rt Hon. Friend, the Secretary of State for Health and Social Care, will chair the National Maternity and Neonatal Taskforce to address the recommendations and develop a new national action plan to drive improvements across maternity and neonatal care.
Asked by: Luke Evans (Conservative - Hinckley and Bosworth)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how many doctors have had to file an estimate for their tax returns as a result of not receiving the appropriate Pension Savings Statements before 31 January 2026.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
The Department of Health and Social Care has indicated that it will not be possible to answer this question within the usual time period. An answer is being prepared and will be provided as soon as it is available.
Asked by: Luke Evans (Conservative - Hinckley and Bosworth)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what his planned timetable is for issuing Pension Savings Statements to doctors.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
The Department of Health and Social Care has indicated that it will not be possible to answer this question within the usual time period. An answer is being prepared and will be provided as soon as it is available.
Asked by: Steve Yemm (Labour - Mansfield)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, when he expects treatments for fatty liver disease to be approved for use on the NHS; what assessment he has made of the readiness of the NHS to make such treatments available; and what steps he is taking to ensure eligible patients will receive these treatments once approved.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
Newly licensed medicines are appraised by the National Institute for Health and Care Excellence (NICE), which is the independent body responsible for developing evidence-based guidance for the National Health Service on whether new medicines represent a clinically and cost-effective use of resources. NICE aims wherever possible to issue draft guidance on new medicines close to the time of licensing. The NHS in England is legally required to fund drugs recommended by NICE, usually within three months of final guidance.
NICE is currently evaluating potential new treatments for metabolic dysfunction-associated steatohepatitis (MASH) in anticipation of the medicines being granted a marketing authorisation by the Medicines and Healthcare Products Regulatory Agency (MHRA) with guidance expected later this year. NHS England is actively preparing to support the potential introduction of new treatments for MASH, including fatty liver disease with fibrosis, alongside the ongoing NICE appraisal process.
The Department and NHS England will continue to work to ensure that, once approved, effective new treatments for fatty liver disease are introduced in a way that is fair, affordable and protects the wider NHS, while ensuring that patients with the greatest clinical need are able to benefit as quickly as possible.
Asked by: Jack Rankin (Conservative - Windsor)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential impact of vaping devices that (a) contain and (b) can be configured to contain more than the standard 2ml tank capacity through (i) interchangeable and (ii) modular components on public health.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
The Tobacco and Vapes Bill will stop vapes and nicotine products from being deliberately branded, promoted, and advertised to children and provides the Government with new powers to restrict the packaging, device appearance, and display of vapes and other nicotine products to stop the next generation from becoming hooked on nicotine.
On 8 October 2025, we launched a Call for Evidence which sought evidence on the size and shape of vapes, vape tanks, and the components of vaping products, including pods, puff-count capacity, and nicotine delivery.
We are now reviewing the responses, and these will help inform decisions around our future regulatory approach once the Tobacco and Vapes Bill has been enacted.
The Department for Environment, Food and Rural Affairs, as part of their upcoming Circular Economy Growth Plan, will consider evidence across a range of interventions, including but not limited to the regulation of product features to support increased recyclability.
Asked by: Maureen Burke (Labour - Glasgow North East)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether his Department has had recent discussions with Marie Curie on funding for the hospice sector.
Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)
Last year, I met key palliative care and end-of-life care stakeholders, including Marie Curie, in a roundtable format with a focus on long-term sector sustainability within the context of our 10-Year Health Plan.
The Government is developing a Palliative Care and End-of-Life Care Modern Service Framework (MSF) for England, and we will consider contracting and commissioning arrangements as part of this work. We recognise that there is currently a mix of contracting models in the hospice sector. By supporting integrated care boards to commission more strategically, we can move away from grant and block contract models. In the long term, this will aid sustainability and help hospices’ ability to plan ahead.
Officials are working closely with Marie Curie and a number of other stakeholders from the hospice sector in the development of the MSF.